|
⚲
|
| Keyboard |
| Stevenson Sharon
✚
|
|
|---|---|
| CIK # | 0001683904 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001683904] | |
| 4 | [0001683904] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Stevenson Sharon | |
| Obalon Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Obalon Therapeutics Inc OBLN
Stock Option · derivative
|
2020-09-16 | Grant | 27,250 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2020-09-16 | Grant | 27,250 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2019-08-06 | Buy | 7,500 | $4.00 | 30,000 |
|
Obalon Therapeutics Inc OBLN
Warrants (Right to Buy) · derivative
|
2019-08-06 | Buy | 5,625 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock (Restricted Stock Units)
|
2019-07-23 | Grant | 78,125 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2018-08-23 | Grant | 27,472 | $1.82 | 49,999 |
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2018-06-13 | Grant | 81,774 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2017-06-06 | Grant | 36,554 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2017-05-09 | Grant | 21,000 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Stock Option (right to buy) · derivative
|
2016-11-09 | Grant | 46,500 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Series E Preferred Stock · derivative
|
2016-10-12 | Conversion | 60,290 | ||
|
Obalon Therapeutics Inc OBLN
Series C Preferred Stock Warrant (right to buy) · derivative
|
2016-10-12 | Conversion | 4,037 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock Warrant (right to buy) · derivative
|
2016-10-12 | Conversion | 4,037 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2016-10-12 | Conversion | 60,290 | ||
|
Obalon Therapeutics Inc OBLN
Series A Preferred Stock · derivative
|
2016-10-12 | Conversion | 143,677 | ||
|
Obalon Therapeutics Inc OBLN
Series B Preferred Stock · derivative
|
2016-10-12 | Conversion | 266,829 | ||
|
Obalon Therapeutics Inc OBLN
Series C Preferred Stock · derivative
|
2016-10-12 | Conversion | 40,995 | ||
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2016-10-12 | Conversion | 190,780 | ||
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2016-10-12 | Conversion | 266,829 | ||
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2016-10-12 | Conversion | 47,629 | ||
| showing 20 of 26 most recent transactions | |||||